Philipp Baaske

Founder & Executive Chairman — NanoTemper

NanoTemper is the proof that the thesis works.

In 2008 Stefan Duhr and I founded NanoTemper Technologies in Munich, out of an LMU laboratory. No large funding. No unicorn headlines. No exit. Just the stubborn conviction that you can build a company out of science — here, in Germany.

A NanoTemper biophysical instrument

What we build

Instruments that make the invisible visible

NanoTemper builds biophysical instruments for drug discovery and for quality control in biomanufacturing. More than 10,000 scientists use them — in pharma, biotech and academia.

The point of all of it is speed for patients: better therapies, sooner, against diseases like cancer and Alzheimer’s.

nanotempertech.com

By the numbers

250 People from 34 nations (status 2024) Munich · Boston · San Francisco · Tokyo · Shanghai
364m Euro cumulative revenue, through end of 2024 Without venture capital
~20% Share of the world market in our category Handelsblatt, Aug 2026
100% Founder-owned — the only company of its kind in the industry Since founding
Philipp Baaske and co-founder Stefan Duhr

The founders

Two physicists. No venture capital.

What started as an LMU spin-out is now a global leader in biophysical tools — and the only 100% founder-owned company in its industry.

We were profitable after two years. Not because we were clever, but because we sold before we had built. We invested in sales and marketing early — our first salesperson sold to the US immediately. To this day, more than half the company works in sales and marketing. We think from the market, not from technology.

NanoTemper was the proof. Now I help the next generation build theirs.

A new Mittelstand out of science — companies that create jobs and hold high-tech niches the world depends on. That is the mission.

Read the mission